Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

fruit

- PMLiVE

Sanofi gains access to Alzheimer’s candidate through $470m Vigil acquisition

A phase 2 trial of the drug is expected to launch in the third quarter of this year

- PMLiVE

The future of customer engagement in biopharma

By Aaron Bean

- PMLiVE

J&J’s Darzalex Faspro recommended by FDA panel of experts for smouldering multiple myeloma

The early precursor of active multiple myeloma accounts for around 15% of all new cases

- PMLiVE

Merck shares promising phase 3 results for Keytruda in ovarian cancer

Approximately 20,890 cases of the disease are expected to be diagnosed in the US this year

- PMLiVE

Improving engagement with clinical trials: time to apply behavioural science

By Rob Horne

- PMLiVE

Bristol Myers Squibb’s perioperative Opdivo regimen granted EC approval in NSCLC

Up to 55% of patients with non-metastatic NSCLC develop recurrence despite curative resection

- PMLiVE

Boehringer’s nerandomilast shows lung function benefit in phase 3 IPF and PPF trials

The candidate is currently under review for both interstitial lung diseases in the EU and US

- PMLiVE

Exploring AI in pharma: how can we achieve lift-off?

By Alex Legg and James Turnbull

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

- PMLiVE

Researchers uncover promising treatment approach for inherited breast cancer

The study evaluated chemotherapy followed by a targeted cancer drug in patients before surgery

- PMLiVE

Clinical trials – overcoming the barriers to improved enrolment and retention

The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of human behaviour and everyday pressures

Why healthcare communications needs creativity, now more than ever

By Sally Robinson

Amiculum

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links